CE stock · MD stock

CE vs MD · rev $10.28B vs P/E 11, $1.93B cap

Celanese Corporation (CE) versus Mednax Inc (MD) — a side-by-side from cached financials, not a winner call.

Celanese Corporation (CE) is a chemicals company listed on US.

Mednax Inc (MD) is a medical care facilities company listed on NYSE.

Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.

MD does not have a complete income-statement cache yet.

CE currently screens at market cap $5.92B. MD currently screens at market cap $1.93B and trailing P/E 11.4.

Not investment advice. Open the CE and MD stock pages for the full models.

Not investment advice.

Popular Stock Comparisons